Head & Neck Cancer Update
By Dr Neil Love
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dr Neil Love
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 9
Reviews: 0
Episodes: 319
Description
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
| Episode | Date |
|---|---|
|
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
|
Dec 20, 2024 |
|
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
|
Dec 18, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers
|
Dec 18, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers
|
Dec 18, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers
|
Dec 17, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis
|
Dec 17, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes
|
Dec 13, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer
|
Dec 13, 2024 |
|
5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2
|
Dec 13, 2024 |
|
Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Dec 10, 2024 |
|
Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer
|
Dec 04, 2024 |
|
Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
|
Dec 03, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Multiple Myeloma
|
Nov 26, 2024 |
|
5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Nov 25, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
|
Nov 22, 2024 |
|
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
|
Nov 22, 2024 |
|
Optimizing the Management of Tenosynovial Giant Cell Tumor
|
Nov 20, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Prostate Cancer
|
Nov 20, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
|
Nov 20, 2024 |
|
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
|
Nov 18, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Lung Cancer
|
Nov 15, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer
|
Nov 15, 2024 |
|
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
|
Nov 08, 2024 |
|
Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences
|
Nov 06, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
|
Nov 05, 2024 |
|
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
|
Nov 01, 2024 |
|
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
|
Oct 29, 2024 |
|
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
|
Oct 25, 2024 |
|
Practical Perspectives: Current Management of Chronic Myeloid Leukemia
|
Oct 23, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Oct 22, 2024 |
|
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
|
Oct 18, 2024 |
|
Peripheral T-Cell Lymphoma
|
Oct 16, 2024 |
|
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
|
Oct 15, 2024 |
|
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
|
Oct 10, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
|
Oct 08, 2024 |
|
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
|
Oct 01, 2024 |
|
Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 24, 2024 |
|
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
|
Sep 20, 2024 |
|
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
|
Sep 17, 2024 |
|
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
|
Sep 11, 2024 |
|
Optimizing the Management of Dedifferentiated Liposarcoma
|
Sep 09, 2024 |
|
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
|
Sep 06, 2024 |
|
Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Sep 04, 2024 |
|
Management of Metastatic Urothelial Bladder Cancer
|
Aug 30, 2024 |
|
Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 28, 2024 |
|
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
|
Aug 23, 2024 |
|
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
|
Aug 21, 2024 |
|
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
|
Aug 20, 2024 |
|
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
|
Aug 16, 2024 |
|
Novel Agents and Strategies in Lung Cancer
|
Aug 13, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Aug 09, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 08, 2024 |
|
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
|
Aug 06, 2024 |
|
An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
|
Aug 02, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
Jul 30, 2024 |
|
Optimizing the Identification of HER2-Low Breast Cancer
|
Jul 30, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
|
Jul 26, 2024 |
|
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Jul 24, 2024 |
|
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
|
Jul 19, 2024 |
|
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
|
Jul 17, 2024 |
|
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
|
Jul 12, 2024 |
|
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
|
Jul 12, 2024 |
|
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
|
Jul 10, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
|
Jul 01, 2024 |
|
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer
|
Jun 17, 2024 |
|
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
|
Jun 12, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jun 11, 2024 |
|
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
|
Jun 07, 2024 |
|
Key Presentations on Lymphoma from Recent Major Conferences
|
May 28, 2024 |
|
Bispecific Antibodies in the Management of Multiple Myeloma
|
May 24, 2024 |
|
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
|
May 24, 2024 |
|
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
|
May 20, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
|
May 13, 2024 |
|
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
|
May 08, 2024 |
|
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
|
May 06, 2024 |
|
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
|
May 03, 2024 |
|
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
|
May 01, 2024 |
|
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 26, 2024 |
|
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
|
Apr 24, 2024 |
|
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
|
Apr 23, 2024 |
|
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
|
Apr 15, 2024 |
|
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
|
Apr 12, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
|
Apr 05, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
|
Apr 05, 2024 |
|
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
|
Apr 03, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Mar 27, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
|
Mar 26, 2024 |
|
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
|
Mar 25, 2024 |
|
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
|
Mar 21, 2024 |
|
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
|
Mar 19, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
|
Mar 15, 2024 |
|
Virtual Case Library: Metastatic Urothelial Bladder Cancer
|
Mar 13, 2024 |
|
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 11, 2024 |
|
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
|
Mar 08, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
|
Mar 06, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Feb 26, 2024 |
|
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
|
Feb 23, 2024 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
|
Feb 16, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
|
Jan 31, 2024 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
|
Jan 23, 2024 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
|
Jan 16, 2024 |
|
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
|
Dec 19, 2023 |
|
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
|
Dec 13, 2023 |
|
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
|
Dec 08, 2023 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
|
Dec 05, 2023 |
|
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
|
Nov 29, 2023 |
|
Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
|
Nov 20, 2023 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
|
Nov 14, 2023 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
|
Nov 10, 2023 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
|
Nov 01, 2023 |
|
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
|
Oct 24, 2023 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
|
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
|
Oct 18, 2023 |
|
Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
|
Oct 17, 2023 |
|
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
|
Oct 13, 2023 |
|
Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
|
Oct 12, 2023 |
|
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
|
Oct 11, 2023 |
|
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
|
Oct 09, 2023 |
|
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
|
Oct 06, 2023 |
|
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
|
Oct 06, 2023 |
|
Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Oct 04, 2023 |
|
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 29, 2023 |
|
Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
|
Sep 27, 2023 |
|
Novel Agents and Strategies in the Treatment of Ovarian Cancer
|
Sep 25, 2023 |
|
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
|
Sep 22, 2023 |
|
Optimizing the Management of Metastatic Pancreatic Cancer
|
Sep 15, 2023 |
|
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
|
Sep 13, 2023 |
|
Meet The Professor: Optimizing the Management of Melanoma
|
Sep 11, 2023 |
|
Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Sep 08, 2023 |
|
The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
|
Sep 05, 2023 |
|
Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
|
Sep 01, 2023 |
|
Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma
|
Aug 30, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
|
Aug 29, 2023 |
|
Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
|
Aug 28, 2023 |
|
Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 25, 2023 |
|
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
|
Aug 23, 2023 |
|
Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
|
Aug 22, 2023 |
|
Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 21, 2023 |
|
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia
|
Aug 18, 2023 |
|
Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 16, 2023 |
|
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue
|
Aug 15, 2023 |
|
Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 11, 2023 |
|
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank
|
Aug 11, 2023 |
|
Optimizing the Management of Metastatic Urothelial Bladder Cancer
|
Aug 09, 2023 |
|
Special Edition — Current and Future Management of Breast Cancer
|
Aug 08, 2023 |
|
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
|
Aug 03, 2023 |
|
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers
|
Aug 02, 2023 |
|
Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
|
Aug 02, 2023 |
|
Immune Thrombocytopenia Edition with Dr Hanny Al-Samkari
|
Jul 28, 2023 |
|
Paroxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro
|
Jul 25, 2023 |
|
Special Edition — Management of Hepatobiliary Cancers
|
Jul 24, 2023 |
|
Special Edition — Management of Urothelial Bladder Cancer
|
Jul 21, 2023 |
|
Special Edition — Current and Future Management of Breast Cancer
|
Jul 21, 2023 |
|
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer
|
Jul 20, 2023 |
|
The Implications of New Research Findings for the Management of Endometrial Cancer
|
Jul 14, 2023 |
|
Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma
|
Jul 06, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series
|
Jun 16, 2023 |
|
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition
|
Apr 19, 2023 |
|
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
|
Apr 12, 2023 |
|
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
|
Mar 02, 2023 |
|
Management of Desmoid Tumors with Dr Mrinal Gounder
|
Feb 28, 2023 |
|
Management of HER2-Altered Non-Small Cell Lung Cancer
|
Feb 21, 2023 |
|
Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
|
Feb 13, 2023 |
|
Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek
|
Feb 09, 2023 |
|
Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
|
Feb 06, 2023 |
|
Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone
|
Feb 02, 2023 |
|
Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan
|
Jan 31, 2023 |
|
HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano
|
Jan 26, 2023 |
|
Management of Gastroesophageal Cancers with Dr Manish Shah
|
Jan 12, 2023 |
|
Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa
|
Jan 05, 2023 |
|
Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog
|
Dec 21, 2022 |
|
Novel Immunotherapeutic Strategies in Melanoma with Dr Omid Hamid
|
Dec 13, 2022 |
|
Thyroid Cancer with Dr Eric Sherman
|
Dec 08, 2022 |
|
Amyloid Light Chain (AL) Amyloidosis with Dr Jeffrey Zonder
|
Dec 06, 2022 |
|
Novel Agents and Strategies in Myelofibrosis with Dr Ruben Mesa
|
Dec 01, 2022 |
|
Management of Renal Cell Carcinoma with Dr Toni Choueiri
|
Nov 29, 2022 |
|
Management of Hepatocellular Carcinoma with Prof Arndt Vogel
|
Nov 21, 2022 |
|
Novel Agents and Strategies in AML with Dr Eytan Stein
|
Nov 17, 2022 |
|
Higher-Risk Myelodysplastic Syndromes with Dr Amy DeZern
|
Nov 15, 2022 |
|
Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences — With Dr Rachna Shroff
|
Nov 10, 2022 |
|
Management of MET-Altered Non-Small Cell Lung Cancer with Dr Rebecca Heist
|
Nov 07, 2022 |
|
Current Management of Myelofibrosis with Dr Brady Stein
|
Nov 03, 2022 |
|
Neuroendocrine Tumors with Dr Pamela Kunz
|
Nov 01, 2022 |
|
BRAF-Mutant Metastatic Melanoma with Prof Axel Hauschild
|
Oct 27, 2022 |
|
Management of RET Fusion-Positive Non-Small Cell Lung Cancer with Dr Justin Gainor
|
Oct 25, 2022 |
|
Management of Nonmetastatic Urothelial Bladder Cancer with Prof Sia Daneshmand
|
Oct 20, 2022 |
|
Management of Small Cell Lung Cancer with Dr Benjamin Levy
|
Oct 06, 2022 |
|
BCMA-Directed Therapies for Multiple Myeloma with Dr Amrita Krishnan
|
Sep 29, 2022 |
|
Management of Localized Non-Small Cell Lung Cancer with Dr Heather Wakelee
|
Sep 26, 2022 |
|
Current and Future Management of Hodgkin Lymphoma with Dr Stephen Ansell
|
Sep 15, 2022 |
|
Interstitial Lung Disease in Patients Receiving Anticancer Therapy with Dr Charles Powell
|
Sep 13, 2022 |
|
Endometrial Cancer Edition with Dr Mansoor Raza Mirza
|
Sep 08, 2022 |
|
Ocular Toxicities in Patients Receiving Anticancer Therapy with Dr Asim Farooq
|
Sep 06, 2022 |
|
Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting with Dr Joshua Sabari
|
Aug 24, 2022 |
|
KRAS-Mutant Non-Small Cell Lung Cancer
|
Aug 18, 2022 |
|
Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting with Dr Brian Slomovitz
|
Aug 16, 2022 |
|
Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting with Dr Ezra Cohen
|
Aug 08, 2022 |
|
Recent Updates in the Management of HER2-Low Breast Cancer with Dr Shanu Modi
|
Aug 02, 2022 |
|
Management of Unresectable Stage III Non-Small Cell Lung Cancer with Drs Jeffrey Bradley and David Spigel
|
Aug 01, 2022 |
|
Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting with Dr Sandy Srinivas
|
Jul 28, 2022 |
|
Management of Cholangiocarcinoma and Other Biliary Tract Cancers with Professor Juan Valle
|
Jul 21, 2022 |
|
Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting with Dr Angela DeMichele
|
Jul 18, 2022 |
|
Recent Updates in HER2-Low Breast Cancer with Dr Adam Brufsky
|
Jul 07, 2022 |
|
Current and Future Management of Follicular Lymphoma with Dr Loretta Nastoupil
|
Jul 05, 2022 |
|
Updates on Ovarian Cancer from SGO 2022 with Dr David O’Malley
|
May 04, 2022 |
|
PARP Inhibitors in Breast Cancer with Dr Judy Garber
|
Apr 20, 2022 |
|
Advances in Soft Tissue Sarcomas with Dr Mark Agulnik
|
Mar 14, 2022 |
|
Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari
|
Mar 10, 2022 |
|
Key Presentations on Advances in Myeloproliferative Neoplasms from ASH 2021 with Dr Prithviraj Bose
|
Mar 07, 2022 |
|
Advances in the Treatment of Hodgkin and Non-Hodgkin Lymphomas from ASH 2021 with Dr Matthew Lunning
|
Feb 21, 2022 |
|
Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from ASH 2021
|
Feb 17, 2022 |
|
Current Issues in the Research and Management of Localized Hormone Receptor-Positive Breast Cancer with Dr Sara Tolaney.
|
Feb 11, 2022 |
|
Recent Advances in the Treatment of Chronic Lymphocytic Leukemia with Dr Peter Hillmen
|
Feb 09, 2022 |
|
Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia with Dr Matthew Davids
|
Feb 02, 2022 |
|
Managing Transplant-Ineligible Newly Diagnosed Multiple Myeloma with Dr Saad Zafar Usmani
|
Jan 31, 2022 |
|
Novel Agents and Strategies for the Treatment of Metastatic Castration-Resistant Prostate Cancer with Dr Evan Yu
|
Jan 21, 2022 |
|
Biomarker-Directed Therapy for Colorectal Cancer with Dr Christopher Lieu
|
Jan 14, 2022 |
|
PARP Inhibition in Pancreatic Cancer with Dr Michael Pishvaian
|
Jan 12, 2022 |
|
Modern Management of Metastatic Castration-Resistant Prostate Cancer with Dr Alan Bryce
|
Jan 03, 2022 |
|
Advances in Genetic Profiling and Targeted Therapies for Colorectal Cancer with Dr Arvind Dasari
|
Dec 20, 2021 |
|
Ovarian Cancer with Dr Bradley Monk
|
Dec 17, 2021 |
|
NSCLC with EGFR Exon 20 Insertion Mutations with Dr Gregory Riely
|
Dec 17, 2021 |
|
Novel Immunotherapeutic Strategies in Melanoma with Dr Adil Daud
|
Dec 13, 2021 |
|
Optimal Management of Hodgkin Lymphoma in Younger and Older Patients with Dr Neil Love
|
Dec 09, 2021 |
|
Advances in Endometrial Cancer with Dr Matthew Powell
|
Dec 08, 2021 |
|
Chronic Lymphocytic Leukemia with Professor Dr Arnon Kater
|
Nov 22, 2021 |
|
Myelodysplastic Syndromes with Dr Michael Savona
|
Nov 15, 2021 |
|
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
|
Nov 08, 2021 |
|
Head and Neck Cancer with Dr Cristina Rodriguez
|
Nov 05, 2021 |
|
Myeloproliferative Neoplasms with Dr Ruben Mesa
|
Nov 01, 2021 |
|
Chronic Myeloid Leukemia with Dr Michael Mauro
|
Oct 26, 2021 |
|
Renal Cell Carcinoma with Dr Sumanta Pal
|
Oct 08, 2021 |
|
Thyroid Cancer with Dr Marcia Brose
|
Oct 04, 2021 |
|
Gastroesophageal Cancers with Dr Samuel Klempner
|
Sep 23, 2021 |
|
Management of HER2-Low Breast Cancer with Dr Ian Krop
|
Sep 23, 2021 |
|
Key Presentations on Gynecologic Cancers from the 2021 ASCO Annual Meeting with Dr Kathleen Moore
|
Sep 02, 2021 |
|
Thyroid Cancer with Dr Lori Wirth
|
Aug 19, 2021 |
|
Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting with Dr Joel Neal
|
Aug 10, 2021 |
|
CAR T-Cell Therapy in Multiple Myeloma with Dr Jesús Berdeja
|
Aug 05, 2021 |
|
Key Presentations on Gastrointestinal Cancers from the 2021 ASCO Annual Meeting with Dr Kristen Ciombor
|
Jul 30, 2021 |
|
Key Presentations on Breast Cancer from the 2021 ASCO Annual Meeting with Dr Sara Tolaney
|
Jul 23, 2021 |
|
Gastroesophageal Cancers with Dr Jaffer Ajani
|
Jul 22, 2021 |
|
Key Presentations on Genitourinary Cancers from the 2021 ASCO Annual Meeting with Dr Arjun Balar
|
Jul 15, 2021 |
|
Progress in Myelodysplastic Syndromes with Dr Guillermo Garcia-Manero
|
Jul 13, 2021 |
|
HER2-Positive Localized Breast Cancer with Dr Adam Brufsky
|
May 11, 2021 |
|
Genomic Assays in Early Breast Cancer
|
May 06, 2021 |
|
Advances in the Management of Amyloid Light Chain Amyloidosis with Dr Morie Gertz
|
Apr 30, 2021 |
|
Advances in the Management of Cholangiocarcinoma with Dr Mitesh Borad
|
Apr 29, 2021 |
|
Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst
|
Apr 12, 2021 |
|
Key Presentations on Non-Hodgkin and Hodgkin Lymphomas from the 2020 ASH Annual Meeting with Dr Laurie Sehn
|
Apr 07, 2021 |
|
Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander
|
Apr 02, 2021 |
|
Side Effects of Hormonal Therapy in Prostate Cancer with Dr Roberto Iacovelli
|
Mar 29, 2021 |
|
Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba
|
Mar 26, 2021 |
|
Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer with Dr Manmeet Ahluwalia
|
Mar 23, 2021 |
|
Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
|
Mar 22, 2021 |
|
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei
|
Mar 19, 2021 |
|
PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín
|
Mar 12, 2021 |
|
Predictors of Response to Cancer Immunotherapy with Prof Solange Peters
|
Mar 12, 2021 |
|
Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael
|
Mar 10, 2021 |
|
Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska
|
Mar 08, 2021 |
|
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
|
Mar 03, 2021 |
|
Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson
|
Mar 01, 2021 |
|
New Targets in Non-Small Cell Lung Cancer with Dr Justin Gainor
|
Feb 26, 2021 |
|
ER-Positive Metastatic Breast Cancer with Dr Erika Hamilton
|
Feb 24, 2021 |
|
Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce
|
Feb 19, 2021 |
|
Current and Future Treatment Strategies for Advanced Ovarian Cancer with Dr Kathleen Moore
|
Feb 19, 2021 |
|
Front-Line Treatment of Chronic Lymphocytic Leukemia with Dr Steven Coutre
|
Feb 16, 2021 |
|
Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting with Dr Aaron T Gerds
|
Feb 12, 2021 |
|
Newly Approved Agents in the Management of Urothelial Bladder Carcinoma with Dr Matthew Galsky
|
Feb 05, 2021 |
|
Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations with Dr Corey Langer
|
Jan 29, 2021 |
|
The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin
|
Jan 19, 2021 |
|
Key Presentations on the Treatment of Multiple Myeloma from the 2020 ASH Annual Meeting with Dr Sagar Lonial
|
Jan 15, 2021 |
|
Current Challenges of COVID-19 in Southern California with Dr David Quinn
|
Jan 08, 2021 |
|
Current Management of and Future Directions in Mesothelioma with Dr Marjorie Zauderer
|
Dec 30, 2020 |
|
The Role of Immunotherapy Combination Approaches in the Management of Metastatic Non-Small Cell Lung Cancer with Dr Stephen Liu
|
Dec 22, 2020 |
|
The Role of PARP Inhibition in the Management of Breast Cancer with Dr Hope Rugo
|
Dec 21, 2020 |
|
The Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Ursula Matulonis
|
Dec 21, 2020 |
|
The Role of PARP Inhibition in the Management of Pancreatic Cancer with Dr Philip A Philip
|
Dec 21, 2020 |
|
The Role of PARP Inhibition in the Management of Prostate Cancer with Dr Maha Hussain
|
Dec 21, 2020 |
|
Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt
|
Dec 15, 2020 |
|
Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers with Dr David O'Malley
|
Dec 10, 2020 |
|
Management of Pancreatic Cancer with Dr Andrew Ko
|
Dec 09, 2020 |
|
Key Recent Data Sets in Gastrointestinal Cancers with Dr Philip A Philip
|
Dec 07, 2020 |
|
Immune Checkpoint Inhibition in Breast Cancer with Dr Sylvia Adams
|
Dec 07, 2020 |
|
The Role of Liquid Biopsy for Cancer Screening with Dr Eric Klein
|
Dec 02, 2020 |
|
Novel Agents Under Investigation in Multiple Myeloma with Dr Peter Voorhees
|
Dec 01, 2020 |
|
Adjuvant Therapy for ER-Positive Breast Cancer with Prof Stephen Johnston
|
Nov 19, 2020 |
|
Management of Non-Small Cell Lung Cancer with ALK and ROS1 Rearrangements with Dr Ross Camidge
|
Nov 18, 2020 |
|
Management of Gastroesophageal Cancers with Dr Daniel Catenacci
|
Nov 16, 2020 |
|
Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer with Dr Ashish Kamat
|
Nov 05, 2020 |
|
Renal Cell Carcinoma
|
Nov 04, 2020 |
|
Acute Myeloid Leukemia with FLT3 Mutations
|
Oct 30, 2020 |
|
Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma
|
Oct 27, 2020 |
|
PARP Inhibition in the Management of Pancreatic Cancer
|
Oct 23, 2020 |
|
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy
|
Oct 21, 2020 |
|
Front-Line Treatment of Chronic Lymphocytic Leukemia
|
Oct 13, 2020 |
|
Hodgkin Lymphoma
|
Oct 02, 2020 |
|
Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition
|
Sep 30, 2020 |
|
PARP Inhibitors in Breast Cancer Edition
|
Sep 23, 2020 |
|
Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
|
Sep 21, 2020 |
|
Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition
|
Sep 17, 2020 |
|
Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition
|
Sep 15, 2020 |
|
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
|
Sep 11, 2020 |
|
Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition
|
Sep 04, 2020 |
|
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition
|
Aug 28, 2020 |
|
Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard
|
Aug 18, 2020 |
|
Oncology Today Special Roundtable: Colorectal Cancer
|
Aug 05, 2020 |
|
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson
|
Aug 01, 2020 |
|
Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer
|
Jun 17, 2020 |
|
Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2
|
Jun 05, 2020 |
|
Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19
|
May 27, 2020 |
|
Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era
|
May 19, 2020 |
|
Dr Kathleen Moore Comments on the Management of Ovarian Cancer During the COVID-19 Pandemic
|
May 15, 2020 |
|
Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic
|
May 03, 2020 |
|
AACR Virtual Spectacular: Dr Leora Horn Comments on the New COVID-19 Lung Cancer Registry
|
Apr 30, 2020 |
|
Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber
|
Apr 24, 2020 |
|
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle
|
Apr 22, 2020 |
|
COVID-19 and Prostate Cancer
|
Apr 09, 2020 |